Expert Opinion on Therapeutic Patents

Shares in the genome
pp. 1401-1403(3)
Author: Thomas S.M.

Pfizer: analysis of patenting 1995 - 1998
pp. 1405-1414(10)
Author: Adams S.

Cholesterol and plasma lipid modifying patents
pp. 1415-1423(9)
Author: Suckling K.E.

Basic fibroblast growth factor: a potential therapeutic agent for the treatment of acute neurodegenerative disorders and vascular insufficiency
pp. 1425-1445(21)
Authors: Moyer J.A.; Wood A.; Zaleska M.M.; Ay I.; Finklestein S.P.; Protter A.A.

Genetic diversity: applications of evolutionary algorithms to combinatorial library design
pp. 1447-1459(13)
Authors: Brown R.; Clark D.

Recent advances in sialidase inhibitors
pp. 1461-1478(18)
Authors: Dowle M.D.; Howes P.D.

Modulation of the activity of transforming growth factor beta
pp. 1479-1486(8)
Author: Jackson R.H.

Antimalarial peroxides in the qinghaosu (artemisinin) and yingzhaosu families
pp. 1487-1493(7)
Author: Posner G.H.

Analysis of patenting within gene therapy
pp. 1495-1505(11)
Author: Nelson J.

Annotated Patent Selections
pp. 1507-1515(9)

2-Phenyl-3-pyridinyl substituted 7-azaindoles as inhibitors of mitogen-activated protein kinase
pp. 1517-1523(7)

Applications for regulatory region of nitric oxide synthase isoforms
pp. 1525-1528(4)